Navigation Links
XTENT Announces CUSTOM II Data Selected for Publication in EuroIntervention
Date:8/26/2008

r adverse cardiac events (MACE) were reported since the one-year analysis, and the incidence of late stent thrombosis for patients treated with Custom NX was zero percent. The CUSTOM I article published in EuroIntervention was recognized by the journal's editorial board as one of the six best papers submitted to the journal during the previous winter, and Lutz Buellesfeld, M.D., of the HELIOS Heart Center in Siegburg, Germany, received an award in conjunction with the publication after presenting it at the annual EuroPCR meeting in May.

The CUSTOM II trial was designed to evaluate the safety and efficacy of Custom NX for the treatment of long and multiple lesions. Of the 100 patients enrolled, 69 patients were enrolled in the long-lesion arm, and 31 patients were enrolled in the two-lesion arm of the study. CUSTOM II enrolled one of the most difficult to treat patient populations ever studied in a DES trial. In the CUSTOM II patient population, the average vessel diameter was 2.57mm and the average lesion length was 28.7mm. Twenty-six percent of the study participants were diabetic. The percentage of patients with ACC/AHA lesion grade B2 or C was 65.1 percent. CUSTOM II's six-month clinical results have been sustained at one year. The target lesion revascularization rate remained constant at four percent, with no new MACE events, and no late stent thrombosis.

The EuroIntervention paper, titled "One year results of a new in-situ length-adjustable stent platform with a biodegradable Biolimus A9 eluting polymer: result of the CUSTOM-II trial," can be accessed at: http://www.europcronline.com/eurointervention/15th_issue/37/.

About the Custom NX(R) DES System

Custom NX is designed to enable a more personalized approach to the treatment of arterial disease based on each patient's individual lesion characteristics. The Custom NX system allows physicians to c
'/>"/>

SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. XTENT Announces European Regulatory Update
2. Legacy Good Samaritan Hospital Surgeons Find BSGI Effective in Determining Extent of Breast Cancer in Patients With Known Diagnosis
3. XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting
4. XTENT Announces Clinical Trial Data to be Presented at Annual EuroPCR Meeting Next Week
5. XTENT Announces First Quarter 2008 Financial Results
6. Study Data Show Asacol(R) (Mesalamine) is Effective in Treating All Extents of Ulcerative Colitis Including Isolated Proctitis
7. XTENT Announces Positive Two-Year CUSTOM I and One-Year CUSTOM II Trial Data for Novel Drug-Eluting Stent System
8. XTENT to Present CUSTOM I and CUSTOM II Trial Data at TCT 2007
9. Novavax Announces Favorable Results from Phase I/IIa Pandemic Influenza Vaccine Program
10. Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery
11. Genmab Announces Upcoming Ofatumumab Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...  Encision Inc. (OTCQB:ECIA), a medical device company owning ... in minimally invasive surgery, today announced financial results for ... The Company posted quarterly net revenue of ... thousand, or $(0.02) per share. These results compare to ... of $311 thousand, or $(0.04) per share, in the ...
(Date:7/29/2014)... Health 2.0 announces Bernard Tyson , CEO of ... Topol , Patrick Soon-Shiong , and Samsung,s President ... Fall Conference this coming Sept. 21-24 in ... set to host the very first Wearable Tech Fashion Runway ... Tech & Wearables: Powering Healthy Lifestyles. The panel will ...
(Date:7/29/2014)... July 29, 2014   ... study investigating the efficacy and safety of MSB0010718C in patients ... a rare and aggressive skin cancer lacking effective treatments   ... cohort Phase I clinical trial for the treatment of solid ... EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, ...
Breaking Medicine Technology:Encision Reports First Quarter Fiscal Year 2015 Results 2Encision Reports First Quarter Fiscal Year 2015 Results 3Encision Reports First Quarter Fiscal Year 2015 Results 4Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 2Kaiser Permanente CEO to Keynote Health 2.0 8th Annual Fall Conference 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 2EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 3EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 4EMD Serono Initiates Phase II Study of Anti-PD-L1 Antibody MSB0010718C in Metastatic Merkel Cell Carcinoma 5
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Satellite Dialysis Opens New Center in Merced, CA 2Satellite Dialysis Opens New Center in Merced, CA 3Satellite Dialysis Opens New Center in Merced, CA 4PDI Reports 2009 Fourth Quarter and Full Year Financial Results 2PDI Reports 2009 Fourth Quarter and Full Year Financial Results 3PDI Reports 2009 Fourth Quarter and Full Year Financial Results 4PDI Reports 2009 Fourth Quarter and Full Year Financial Results 5PDI Reports 2009 Fourth Quarter and Full Year Financial Results 6PDI Reports 2009 Fourth Quarter and Full Year Financial Results 7PDI Reports 2009 Fourth Quarter and Full Year Financial Results 8PDI Reports 2009 Fourth Quarter and Full Year Financial Results 9PDI Reports 2009 Fourth Quarter and Full Year Financial Results 10PDI Reports 2009 Fourth Quarter and Full Year Financial Results 11PDI Reports 2009 Fourth Quarter and Full Year Financial Results 12PDI Reports 2009 Fourth Quarter and Full Year Financial Results 13PDI Reports 2009 Fourth Quarter and Full Year Financial Results 14PDI Reports 2009 Fourth Quarter and Full Year Financial Results 15PDI Reports 2009 Fourth Quarter and Full Year Financial Results 16PDI Reports 2009 Fourth Quarter and Full Year Financial Results 17PDI Reports 2009 Fourth Quarter and Full Year Financial Results 18PDI Reports 2009 Fourth Quarter and Full Year Financial Results 19PDI Reports 2009 Fourth Quarter and Full Year Financial Results 20PDI Reports 2009 Fourth Quarter and Full Year Financial Results 21PDI Reports 2009 Fourth Quarter and Full Year Financial Results 22PDI Reports 2009 Fourth Quarter and Full Year Financial Results 23PDI Reports 2009 Fourth Quarter and Full Year Financial Results 24PDI Reports 2009 Fourth Quarter and Full Year Financial Results 25PDI Reports 2009 Fourth Quarter and Full Year Financial Results 26PDI Reports 2009 Fourth Quarter and Full Year Financial Results 27PDI Reports 2009 Fourth Quarter and Full Year Financial Results 28PDI Reports 2009 Fourth Quarter and Full Year Financial Results 29PDI Reports 2009 Fourth Quarter and Full Year Financial Results 30PDI Reports 2009 Fourth Quarter and Full Year Financial Results 31PDI Reports 2009 Fourth Quarter and Full Year Financial Results 32PDI Reports 2009 Fourth Quarter and Full Year Financial Results 33
(Date:7/29/2014)... 29, 2014 Award-winning inventor Michael Croix has ... neutralizer specifically designed to absorb embarrassing odors in the office. ... easily be stored in a desk drawer. This compact packaging ... users will simply sit on the pad and poof away! ... office and then BAM, someone appears out of nowhere. It’s ...
(Date:7/29/2014)... (PRWEB) July 29, 2014 Riverdale Urgent ... what they do. Through their presence at local events, ... to be more than just a medical service for ... Care donated money in support of Riverdale RiverFest and ... community event that features local musicians and entertainers, arts ...
(Date:7/29/2014)... Lean and Lovely, an affordable and short program, claims ... wear a bikini in the near future. This has caught ... , “Our Lean and Lovely review shows that ... levels. Neither your age nor your body shape matters, which ... the beginning, you will achieve the results that you have ...
(Date:7/29/2014)... AZ (PRWEB) July 29, 2014 Current ... was prescribed pain medication post foot surgery during his first ... time in foot surgery – twice on one foot, once ... prescription drugs. “I broke my foot a year ago and ... was recommended to Jon by a friend from home who’d ...
(Date:7/29/2014)... PeopleKeys today announced that they are launching a ... train and certify others in applied DISC behavioral analysis. ... will be taught by PeopleKeys Master Coach Dan Mucci ... a live Tele-course over the span of 10 weeks ... Trainer course will use a combination of real-time online ...
Breaking Medicine News(10 mins):Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 2Health News:Award-Winning Inventor Michael Croix Launches an Indiegogo Campaign for PoofPad 3Health News:Riverdale Urgent Care of the Bronx, NY Puts a Face Back on Medicine 2Health News:Riverdale Urgent Care of the Bronx, NY Puts a Face Back on Medicine 3Health News:Lean and Lovely: Review Examining Neghar Fonooni’s Program Released 2Health News:Back2Basics Sober Living Resident Overcomes Obstacle in Early Sobriety 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 2Health News:PeopleKeys Announces New Certified Behavioral Consultant Trainer Course 3
... Nile Therapeutics, Inc., (Nasdaq: NLTX ), announced today ... 27th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14th, ... The Westin St. Francis Hotel in San Francisco, CA. ... clinical development programs for its lead compound, CD-NP, a novel ...
... Antonio Villaraigosa, Cal State LA President James Rosser, ... for the construction dedication ceremony of its new ... SA (Grifols), a global healthcare company based in ... Villaraigosa., Cal State LA President James Rosser, Councilman ...
... 50 labor organizations, including United Healthcare Workers and the ... to overturn ban on same-sex marriageOAKLAND, Calif., Jan. 13 ... organizations, including United Healthcare Workers (UHW) and the California ... support of the three lawsuits now challenging Proposition 8, ...
... prescribing of cholesterol-lowering drugs, experts say , , ... start taking results of a recent drug company-sponsored ... be taking cholesterol-lowering statin medications, experts say. , ... in November 2008. The study was cut short, ...
... Tricyclic medications helped with pain, fatigue and depression, ... -- Antidepressants may help people living with the ... improve their quality of life, new research shows. ... of Klinikum Saarbrucken in Germany, found that fibromyalgia ...
... Then warm up - and protect yourself from the dangers ... temperatures are hitting most of the country this week, but ... long winter months. If you do go outside for some ... yourself from frostbite . When body tissues are frostbitten, ...
Cached Medicine News:Health News:Nile Therapeutics to Present at the 27th Annual J.P. Morgan Healthcare Conference 2Health News:Grifols Celebrates Initial Construction of New IVIG Facility with Los Angeles Officials and Dignitaries 2Health News:Calif. Labor Unions Unite to Fight Prop 8 2Health News:Millions More Americans Might Be Placed on Statins 2Health News:Millions More Americans Might Be Placed on Statins 3Health News:Is Jack Frost Nipping At Your Nose? 2Health News:Is Jack Frost Nipping At Your Nose? 3
6.5mm diameter handpiece; 75mm handle with grooves for grip; Standard male luer taper fits most cannula hub and female luer taper....
Hook Shaped Tip , Curved to the Left; with 30 cm long silicone tubing with connector; overall length 40mm; stainless steel...
... forceps are designed for endomyocardial biopsies. ... a 3-pull ring handle, stainless steel cutting jaws, ... rotates to accommodate any position. ,A spring in ... jaws are opened by moving the double rings ...
The only solution for in-line digital measurement...
Medicine Products: